HBV Discovery Services
A Platform Supporting HBV Drug Discovery
A broad assay platform for the discovery of agents for the treatment of chronic HBV infection.
Services for assay establishment and validation, compound screening and profiling, and support of preclinical studies and clinical trials.
- Drug screening using HBV producing cell lines
- HBV infectious assays
- Reporter assays
- Core protein expression
- Compound profiling
- Clinical virology
- Animal models
- Immunological assays supporting animal models
HBV Drug Discovery
Related Content
The Son of Sevenless (SOS) protein is a guanine nucleotide exchange factor that acts as a key activator for KRAS...
VIEW RESOURCEThe RAS family of small GTPases are among the most frequently mutated oncogenes in human cancer. Previously viewed as undruggable,...
VIEW RESOURCE